Idiopathic pulmonary hemosiderosis: a review of the treatments used during the past 30 years and future directions.
Saha BK, Milman NT.
Clin Rheumatol. 2021 Jul;40(7):2547-2557. doi: 10.1007/s10067-020-05507-4. Epub 2020 Nov 12.
PMID:33184706
Adult patients with idiopathic pulmonary hemosiderosis: a comprehensive review of the literature.
Saha BK, Bonnier A, Saha S, Saha BN, Shkolnik B.
Clin Rheumatol. 2022 Jun;41(6):1627-1640. doi: 10.1007/s10067-022-06104-3. Epub 2022 Feb 18.
PMID:35179664
Liposteroid Therapy for Idiopathic Pulmonary Hemosiderosis: A Scoping Review of the Literature.
Saha BK, Milman NT.
Prague Med Rep. 2022;123(2):65-81. doi: 10.14712/23362936.2022.7.
PMID:35507939
Celiac disease and idiopathic pulmonary hemosiderosis: a literature review of the Lane-Hamilton syndrome.
Tryfon S, Papadopoulou E, Psarros G, Agrafiotis M, Saroglou M.
Postgrad Med. 2022 Nov;134(8):732-742. doi: 10.1080/00325481.2022.2109121. Epub 2022 Aug 8.
PMID:35912848
Proposed Pathogenesis of Diffuse Alveolar Hemorrhage in Idiopathic Pulmonary Hemosiderosis.
Saha BK, Chong WH, Saha S, Aiman A, Bonnier A.
Lung. 2022 Apr;200(2):205-215. doi: 10.1007/s00408-022-00523-4. Epub 2022 Mar 10.
PMID:35267072
Differentiation of idiopathic pulmonary hemosiderosis from rheumatologic and autoimmune diseases causing diffuse alveolar hemorrhage: establishing a diagnostic approach.